Coronavirus Testing Suspended at Boston Lab Due to Nearly 400 False Positives

By B.N. Frank

False positives with coronavirus testing are being reported so often that it makes you wonder how many ARE NOT being reported.

Unfortunately, this hasn’t stopped testing or the introduction and marketing of new testing kits or any of the COVID-19 mandates being opposed by American doctors as well as citizens and people worldwide. It also hasn’t stopped invasive and sometimes harmful screening procedures (see 123, 4567).

From NBCNews:

Coronavirus testing at Boston lab suspended after nearly 400 false positives

An investigation by the Massachusetts Department of Public Health found that there were at least 383 erroneous positive results.

A Boston lab suspended coronavirus testing after an investigation uncovered nearly 400 false positive COVID-19 results.

Orig3n, a biotechnology company which counts dozens of nursing homes as its clients, ceased testing on Aug. 8 at the request of the Massachusetts Department of Public Health. The suspension came days after state health officials became aware of an unusually high number of positive coronavirus tests.

An investigation found that there were at least 383 inaccurate positive results from the lab that, upon re-testing, came back as negative.

On Aug. 27, the MDPH said it notified Orig3n they had been cited with “three significant certification deficiencies that put patients at immediate risk of harm.”

“The Boston lab is required to respond with a written plan of correction, and if action is not taken it can face sanctions,” a health department spokesperson said in a statement to NBC News on Wednesday.

The health department said roughly 60 nursing homes either still are or have been clients of Orig3n.

Read full article

Another product being considered by the FDA for illness screening: biosensors implanted under the skin. Given the FDA’s embarrassing track record of approving ineffective and UNSAFE products (see 1234567) perhaps it’s time to stop and re-evaluate how to proceed with all of this (see 12).

Original Article

 


Image 1

Image 2

Image 3

Image 4

0